Tags: Drug.

Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial name Masivet. It has been available in Europe since the second part of 2009. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.Masitinib is being studied for several human conditions including cancers. It is used in Europe to fight orphan diseases.

Masitinib.svg
ATC prefix
L01
ATC suffix
XE22
CAS number
790299-79-5
IUPAC name
4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-[4-(pyridin-3-yl)-13-thiazol-2-yl]aminophenyl)benzamide
PubChem
10074640

Loading...

This page contains content from the copyrighted Wikipedia article "Masitinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.